Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: The EMPOWER cluster randomized trial

JAMA Internal Medicine

Volumn 174, Issue 6, 2014, Pages 890-898

  Tannenbaum, Cara ^a   Martin, Philippe ^a   Tamblyn, Robyn ^b   Benedetti, Andrea ^b,c   Ahmed, Sara ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE;

AGED; AGING; ANXIETY DISORDER; ARTICLE; CLUSTER ANALYSIS; COMMUNITY; CONTROLLED STUDY; CONVERSATION; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EMPOWERMENT; FEMALE; FOLLOW UP; HUMAN; INAPPROPRIATE PRESCRIBING; INSOMNIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN; PATIENT CARE; PATIENT EDUCATION; PHARMACIST; PHARMACY; PHYSICIAN; POLYPHARMACY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; SCREENING TEST; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; BENZODIAZEPINES; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; PATIENT EDUCATION AS TOPIC; POWER (PSYCHOLOGY); PROCESS ASSESSMENT (HEALTH CARE); SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84902164004     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.949     Document Type: Article

References (46)

1. Oshima Lee E, Emanuel EJ. Shared decision making to improve care and reduce costs. N Engl J Med. 2013;368(1):6-8.
2. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288(19):2469-2475. (Pubitemid 35340544)
3. Bardes CL. Defining "patient-centered medicine". N Engl J Med. 2012;366(9):782-783.
4. Katz SJ, Hawley S. The value of sharing treatment decision making with patients: expecting too much? JAMA. 2013;310(15):1559-1560.
5. Cassel CK, Guest JA. Choosing wisely: helping physicians and patients make smart decisions abou. Their care. JAMA. 2012;307(17):1801-1802.
6. American Geriatrics Society. Choosing Wisely website. Five things physicians and patients should question. 2013. http://www.choosingwisely.org/wp- content/uploads/2013/01/about-choosingwisely-fivethings.pdf. Accessed February 28, 2014.
7. Tannenbaum C, Paquette A, Hilmer S, Holroyd-Leduc J, Carnahan R. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging. 2012;29(8):639-658.
8. Woolcott JC, Richardson KJ,Wiens MO, et al. Meta-analysis of The impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169(21):1952-1960.
9. Zint K, Haefeli WE, Glynn RJ, Mogun H, Avorn J, Stürmer T. Impact of drug interactions, dosage, and duration of Therapy of The risk of hip fracture associated with benzodiazepine use in older adults. Pharmacoepidemiol Drug Saf. 2010;19(12):1248-1255.
10. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J AmGeriatr Soc. 2012;60(4):616-631.
11. BrekkeM, Rognstad S, Straand J, et al. Pharmacologically inappropriate prescriptions for elderly patients in general practice: how common? baseline data from The Prescription Peer Academic Detailing (Rx-PAD) study. Scand J Prim Health Care. 2008;26(2):80-85. (Pubitemid 351873981)
12. van der Hooft CS, Jong GW, Dieleman JP, et al. Inappropriate drug prescribing in older adults. The updated 2002 Beers criteria-a population-based cohort study. Br J Clin Pharmacol. 2005;60(2):137-144. (Pubitemid 41075898)
13. Fourrier A, Letenneur L, Dartigues JF, Moore N, Bégaud B. Benzodiazepine use in an elderly community-dwelling population: characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol. 2001;57(5):419-425. (Pubitemid 33787193)
14. Préville M, Bossé C, Vasiliadis HM, et al. Correlates of potentially inappropriate prescriptions of benzodiazepines among older adults: results fro. The ESA study. Can J Aging. 2012;31(3):313-322.
15. Gallagher HC. Addressin. The issue of chronic, inappropriate benzodiazepine use: how can pharmacists play a role? Pharmacy. 2013;1(2):65-93.
16. Parr JM, Kavanagh DJ, Young RM, McCafferty K. Views of general practitioners and benzodiazepine users on benzodiazepines: a qualitative analysis. Soc Sci Med. 2006;62(5):1237-1249. (Pubitemid 43129587)
17. Srisurapanont M, Garner P, Critchley J, Wongpakaran N. Benzodiazepine prescribing behaviour and attitudes: a survey among general practitioners practicing in northern Thailand. BMC FamPract. 2005;6:27.
18. Cook JM, Marshall R, Masci C, Coyne JC. Physicians' perspectives on prescribing benzodiazepines for older adults: a qualitative study. J Gen Intern Med. 2007;22(3):303-307. (Pubitemid 46941221)
19. Tamblyn R, Eguale T, Buckeridge DL, et al. The effectiveness of a new generation of computerized drug alerts in reducin. The risk of injury from drug side effects: a cluster randomized trial. J AmMed Inform Assoc. 2012;19(4):635-643.
20. Martin P, Tamblyn R, Ahmed S, Tannenbaum C. A drug education tool developed for older adults changes knowledge, beliefs and risk perceptions about inappropriate benzodiazepine prescriptions in The elderly. Patient Educ Couns. 2013;92(1):81-87.
21. Donohue JM, Cevasco M, Rosenthal MB. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med. 2007;357(7): 673-681. (Pubitemid 47267237)
22. Greene JA, Choudhry NK, Kesselheim AS, Brennan TA, ShrankW. Changes in direct-toconsumer pharmaceutical advertising following shifts from prescription-only to over-the-counter status. JAMA. 2012;308(10):973-975.
23. Patient empowerment-who empowers whom? Lancet. 2012;379(9827):1677.
24. Martin P, Tamblyn R, Ahmed S, Tannenbaum C. An educational intervention to reduc. The use of potentially inappropriate medications among older adults (EMPOWER study): protocol for a cluster randomized trial. Trials. 2013;14:80.
25. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool formild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699. (Pubitemid 41623495)
26. Pachana NA, Byrne GJ, Siddle H, Koloski N, Harley E, Arnold E. Development and validation of The Geriatric Anxiety Inventory. Int Psychogeriatr. 2007;19(1):103-114. (Pubitemid 44953329)
27. Stewart R, NiessenWJ, Broer J, Snijders TA, Haaijer-Ruskamp FM, Meyboom-De Jong B. General Practitioners reduced benzodiazepine prescriptions in an intervention study: a multilevel application. J Clin Epidemiol. 2007;60(10):1076-1084.
28. GorgelsWJ, Oude Voshaar RC, Mol AJ, et al. Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study. Drug Alcohol Depend. 2005;78(1):49-56. (Pubitemid 40354176)
29. Holden JD, Hughes IM, Tree A. Benzodiazepine prescribing and withdrawal for 3234 patients in 15 general practices. FamPract. 1994;11(4):358-362.
30. Bashir K, KingM, AshworthM. Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br J Gen Pract. 1994;44(386): 408-412. (Pubitemid 24292665)
31. Kaur S, Mitchell G, Vitetta L, Roberts MS. Interventions that can reduce inappropriate prescribing in The elderly: a systematic review. Drugs Aging. 2009;26(12):1013-1028.
32. Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC. Interventions to improv. The appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2012;5:CD008165.
33. Monane M, Matthias DM, Nagle BA, Kelly MA. Improving prescribing patterns fo. The elderly through an online drug utilization review intervention: a system linkin. The physician, pharmacist, and computer. JAMA. 1998;280(14):1249-1252. (Pubitemid 28469231)
34. Eldridge SM, Ashby D, Kerry S. Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method. Int J Epidemiol. 2006;35(5):1292-1300. (Pubitemid 44605554)
35. Ukoumunne OC, Forbes AB, Carlin JB, Gulliford MC. Comparison of The risk difference, risk ratio and odds ratio scales for quantifyin. The unadjusted intervention effect in cluster randomized trials. Stat Med. 2008;27(25):5143- 5155.
36. McAlister FA, Straus SE, Guyatt GH, Haynes RB; Evidence-Based MedicineWorking Group. Users' guides t. The medical literature, XX: integrating research evidence wit. The care of The individual patient. JAMA. 2000;283(21):2829-2836. (Pubitemid 30387829)
37. Salzman C. Clinical Geriatric Psychopharmacology. Baltimore, MD: LippincottWilliams & Wilkins; 1998.
38. Pimlott NJ, Hux JE,Wilson LM, Kahan M, Li C, RosserWW. Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial. CMAJ. 2003;168(7):835-839. (Pubitemid 36433936)
39. TenWolde GB, Dijkstra A, van Empelen P, van den HoutW, Neven AK, Zitman F. Long-term effectiveness of computer-generated tailored patient education on benzodiazepines: a randomized controlled trial. Addiction. 2008;103(4):662-670. (Pubitemid 351389283)
40. TenWolde GB, Dijkstra A, Van Empelen P, Neven AK, Zitman FG. Social-cognitive predictors of intended and actual benzodiazepine cessation among chronic benzodiazepine users. Addict Behav. 2008;33(9):1091-1103.
41. GorgelsWJ, Oude Voshaar RC, Mol AJ, et al. Predictors of discontinuation of benzodiazepine prescription after sending a letter to long-term benzodiazepine users in family practice. FamPract. 2006;23(1):65-72. (Pubitemid 43174688)
42. Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG. Discontinuing medications: a novel approach for revisin. The prescribing stage of The medication-use process. J AmGeriatr Soc. 2008;56(10):1946-1952.
43. Parr JM, Kavanagh DJ, Cahill L, Mitchell G, McD Young R. Effectiveness of current treatment approaches for benzodiazepine discontinuation: ameta-analysis. Addiction. 2009;104(1):13-24.
44. Voshaar RC, Couvée JE, van BalkomAJ, Mulder PG, Zitman FG. Strategies for discontinuing long-term benzodiazepine use: meta-analysis. Br J Psychiatry. 2006;189:213-220. (Pubitemid 44343465)
45. Briesacher BA, Soumerai SB, Field TS, Fouayzi H, Gurwitz JH. Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes. Arch Intern Med. 2010;170(8):693-698.
46. Tannenbaum C, Tsuyuki RT. The expanding scope of pharmacists' practice: implications for physicians. CMAJ. 2013;185(14):1228-1232.